Mesoblast prices pediatric stem cell treatment at $1.55 million – BioWorld

back pain,” Itescu said. Mesoblast's Revascor (rexlemestrocel-L), a second-generation allogeneic, STRO3-immunoselected, and industrially …
Source: back pain